Bone Biologics (BBLGW) Accumulated Depreciation (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Accumulated Depreciation for 2 consecutive years, with $333.0 as the latest value for Q3 2017.
- Quarterly Accumulated Depreciation rose 50.68% to $333.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $333.0 through Sep 2017, up 50.68% year-over-year, with the annual reading at $261.0 for FY2016, N/A changed from the prior year.
- Accumulated Depreciation for Q3 2017 was $333.0 at Bone Biologics, up from $309.0 in the prior quarter.
- The five-year high for Accumulated Depreciation was $333.0 in Q3 2017, with the low at $141.0 in Q1 2016.